ReNAgade Therapeutics
Cambridge
About ReNAgade Therapeutics
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $300.0M
- Funding stage: M&A
- Last round: Series A (May 2023)
- Website: renagadetx.com
- Phone: 617-456-8652
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/renagade-therapeutics-87068 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.